Clinical trial
Combination Chemotherapy Followed by Bone Marrow or Stem Cell Transplantation in…
NCT00002508 · Temple University, Other · Completed
Key facts
| NCT number | NCT00002508 |
|---|---|
| Title | Combination Chemotherapy Followed by Bone Marrow or Stem Cell Transplantation in Treating Patients With Relapsed or Refractory Germ Cell Tumors |
| Official title | INTENSIVE CHEMOTHERAPY FOR RELAPSED OR REFRACTORY GERM CELL TUMORS EMPLOYING HIGH-DOSE CARBOPLATIN, ETOPOSIDE, AND THIOTEPA WITH AUTOLOGOUS BONE MARROW RESCUE FOR PATIENTS 15 TO 60 YEARS OF AGE |
| Lead sponsor | Temple University, Other |
| Collaborators | Fox Chase Cancer Center |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Extragonadal Germ Cell Tumor, Ovarian Cancer, Testicular Germ Cell Tumor |
| Intervention type | Drug, Procedure |
| Interventions | carboplatin, etoposide, autologous bone marrow transplantation, peripheral blood stem cell transplantation |
| Start date | Nov 1, 1990 |
| Primary completion | Sep 1, 2001 |
| Completion | Sep 1, 2001 |
| First posted | Mar 11, 2004 |
| Last update posted | Oct 1, 2010 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: